When should we be collecting specimens for therapeutic drug monitoring of
slow-release lithium preparations?
****************************************
Bruce Campbell FRCPA FAACB
Sullivan Nicolaides Pathology
Ph 61 (0)7 3377 8672
Fax 61 (0)7 3870 5989
Email [log in to unmask]
****************************************
**********Confidentiality/Limited Liability Statement***************
This message and any files transmitted with it contain privileged and
confidential information intended only for the use of the addressee
named above. If you are not the intended recipient of this message,
you must not disseminate, copy or take any action in reliance on it.
If you have received this message in error, please notify Sullivan
Nicolaides Pathology immediately.
Any views expressed in this message are those of the individual sender
and Sullivan Nicolaides Pathology accepts no liability for the content
of this message except where the sender specifically states them to be
the views of Sullivan Nicolaides Pathology.
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|